Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Soligenix stock
Learn how to easily invest in Soligenix stock.
Soligenix Inc is a biotechnology business based in the US. Soligenix shares (SNGX) are listed on the NASDAQ and all prices are listed in US Dollars. Soligenix employs 13 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Soligenix
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – SNGX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Soligenix stock price (NASDAQ: SNGX)Use our graph to track the performance of SNGX stocks over time.
Soligenix shares at a glance
|Latest market close||$0.58|
|52-week range||$0.38 - $1.32|
|50-day moving average||$0.54|
|200-day moving average||$0.74|
|Wall St. target price||$3.88|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.35|
Buy Soligenix shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Soligenix stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Soligenix price performance over time
|1 week (2022-06-28)||7.41%|
|1 month (2022-06-03)||13.73%|
|3 months (2022-04-05)||-20.55%|
|6 months (2022-01-05)||-15.94%|
|1 year (2021-07-02)||-44.23%|
|2 years (2020-07-02)||-70.41%|
|3 years (2019-07-05)||0.785|
|5 years (2017-07-05)||2.05|
|Gross profit TTM||$95,628|
|Return on assets TTM||-34.2%|
|Return on equity TTM||-121.64%|
|Market capitalisation||$25 million|
TTM: trailing 12 months
Soligenix share dividends
We're not expecting Soligenix to pay a dividend over the next 12 months.
Have Soligenix's shares ever split?
Soligenix's shares were split on a 1:10 basis on 6 October 2016. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Soligenix shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Soligenix shares which in turn could have impacted Soligenix's share price.
Soligenix share price volatility
Over the last 12 months, Soligenix's shares have ranged in value from as little as $0.38 up to $1.32. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Soligenix's is 1.2713. This would suggest that Soligenix's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Soligenix, Inc. , a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has completed Phase III clinical trial for the treatment of treat cutaneous T-cell lymphoma; and SGX942, an innate defense regulator technology that is in Phase III clinical trial for the treatment of inflammatory diseases, including oral mucositis in head and neck cancer. This segment also offers proprietary formulations of oral beclomethasone 17,21-dipropionate for the prevention/treatment of gastrointestinal disorders characterized by severe inflammation, including SGX203 for pediatric Crohn's disease; and SGX302 that is in Phase I/II clinical trial for the treatment of mild-to-moderate psoriasis. The Public Health Solutions segment is involved in the development of RiVax, a ricin toxin vaccine candidate, which has completed Phase Ia and Ib clinical trials; SGX943, a therapeutic candidate that is in pre-clinical stage for the treatment of antibiotic resistant and emerging infectious diseases; ThermoVax, a technology in pre-clinical development for thermostabilizing vaccines; and CiVax, a vaccine candidate in pre-clinical development for the prevention of COVID-19. The company was formerly known as DOR BioPharma, Inc.
Frequently asked questionsWhat percentage of Soligenix is owned by insiders or institutions?
Currently 0.304% of Soligenix shares are held by insiders and 7.609% by institutions. How many people work for Soligenix?
Latest data suggests 13 work at Soligenix. When does the fiscal year end for Soligenix?
Soligenix's fiscal year ends in December. Where is Soligenix based?
Soligenix's address is: 29 Emmons Drive, Princeton, NJ, United States, 08540 What is Soligenix's ISIN number?
Soligenix's international securities identification number is: US8342233074 What is Soligenix's CUSIP number?
Soligenix's Committee on Uniform Securities Identification Procedures number is: 258094101
More guides on Finder
How to buy Citrine Global (CTGL) stock when it goes public
Everything we know about the Citrine Global IPO, plus information on how to buy in.
How to buy Genelux Corporation (GNLX) stock when it goes public
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
How to buy Magic Empire Global (MEGL) stock when it goes public
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Ask an Expert